2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial
Prospective Randomized Trial on 2D Versus 3D Laparoscopic Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II
1 other identifier
interventional
36
1 country
1
Brief Summary
This prospective randomized pilot study is aimed to verify if the operative time of a total laparoscopical hysterectomy (TLH) with pelvic lymphadenectomy for endometrial cancer FIGO stage IB-II could be reduced using 3D laparoscopy versus standard laparoscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 10, 2014
CompletedFirst Posted
Study publicly available on registry
December 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedJune 8, 2015
June 1, 2015
5 months
December 10, 2014
June 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Operative time for laparoscopic total hysterectomy with pelvic lymphadenectomy
Operative time will be calculated from the entrance in the abdominal cavity to the closure of the skin trocar accesses
intraoperative
Secondary Outcomes (1)
number of participants with intra or post operative complications
two years
Study Arms (2)
3D Laparoscopy
EXPERIMENTALLaparoscopic total hysterectomy with pelvic lymphadenectomy are performed with 3D Laparoscopic technology. A 10 mm port is inserted at the umbilicus for the telescope. Once pneumoperitoneum (12 mmHg) is achieved, intra-abdominal visualization will be obtained with a 0° high-definition 3D telescope. Two additional 5 mm ports are placed under direct visualization. One more 5- mm trocar is inserted in the right mid abdomen at the level of the umbilicus. The instruments used include bipolar grasper, monopolar scissors, monopolar hook, various graspers and a suction irrigation system
Standard Laparoscopy
ACTIVE COMPARATORLaparoscopic total hysterectomy with pelvic lymphadenectomy are performed with standard laparoscopy technology. A 10 mm port is inserted at the umbilicus for the telescope. Once pneumoperitoneum (12 mmHg) is achieved, intra-abdominal visualization will be obtained with a 0° high-definition telescope. Two additional 5 mm ports are placed under direct visualization. One more 5 mm trocar is inserted in the right mid abdomen at the level of the umbilicus. The instruments used include bipolar grasper, monopolar scissors, monopolar hook, various graspers and a suction irrigation system.
Interventions
Eligibility Criteria
You may not qualify if:
- Age ≤ 75 years
- Patient's informed consent
- American Society of Anesthesiologists: \< class III or IV
- No actual pregnancies or P.I.D.
- No previous major abdominal surgical procedures
- Endometrial cancer FIGO stages IB-II
- Endometrioid histotype
- No previous radiotherapy on pelvic fields
- No uterine size larger than conform 10 weeks gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Catholic University of the Sacred Heartlead
- Fagotti, Anna, M.D.collaborator
- Fanfani, Francesco, M.D.collaborator
Study Sites (1)
Catholic University of the Sacred Heart
Rome, Italy, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Dip per la Tutela della Salute della Donna e della Vita Nascente, del Bambino e dell'Adolescente
Study Record Dates
First Submitted
December 10, 2014
First Posted
December 19, 2014
Study Start
October 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
June 8, 2015
Record last verified: 2015-06